Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-30

FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for TRULICITY (dulaglutide) submitted by Eli Lilly and Company, updating the label as requested in the supplemental appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRULICITY (DULAGLUTIDE)

Snippet

SUPPL AP for TRULICITY (DULAGLUTIDE)